TipRanks
Go Ultimate55% OFF

Climb Bio (CLYM) Drug Pipeline

Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
BudoprutugSystemic Lupus Erthematosusphase1AndPhase2RecruitingA Phase 1b/2a Study of Budoprutug in Systemic Lupus Erythematosus (SLE)Apr 27, 2026―
Clym116Healthy VolunteersPhase IRecruitingA Phase 1 Study of CLYM116 in Normal Healthy VolunteersNov 18, 2025
BudoprutugPrimary Membranous NephropathyPhase IIRecruitingA Phase 2 Study of Budoprutug in Subjects With Primary Membranous NephropathyJul 24, 2025
BudoprutugHealthy VolunteersearlyPhase1CompletedA Phase 1 Study of Budoprutug (TNT119) Subcutaneous and Intravenous Injections in Normal Healthy VolunteersJul 21, 2025
BudoprutugImmune Thrombocytopenia (Itp), Itp, Biologics, Monoclonal, Anti-Cd19phase1AndPhase2RecruitingA Phase 1b/2a Study of Budoprutug in Subjects With Immune Thrombocytopenia (ITP)Jun 20, 2025
BudoprutugSystemic Lupus ErythematosusPhase IRecruitingA Phase 1b Study of Budoprutug in Systemic Lupus Erythematosus (SLE)May 06, 2025

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Climb Bio, Inc. (CLYM) have in its pipeline
Climb Bio CLYM is currently developing the following drugs: Budoprutug, Clym116. These drug candidates are in various stages of clinical development as the company works toward FDA approval.